CD44 is widely used as a marker for breast tumor–initiating cells [139,140] and experimental analyses show that CD44 contributes to the pro–tumorigenic behaviour of breast cancer cells by stimulating cell proliferation, migration, invasion, and plasticity [141,142]. This evidence concerns the gene CD44 and breast cancer.